DFAI vs. XBI
DFAI (Dimensional International Core Equity Market ETF) and XBI (SPDR S&P Biotech ETF) are both exchange-traded funds - DFAI is a Foreign Large Cap Equities fund actively managed by Dimensional, while XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. DFAI is actively managed, while XBI is passively managed. Over the past 5 years, DFAI returned 9.68%/yr vs 0.52%/yr for XBI. At a 0.50 correlation, their price movements are largely independent. DFAI charges 0.18%/yr vs 0.35%/yr for XBI.
Performance
DFAI vs. XBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DFAI achieves a 10.55% return, which is significantly lower than XBI's 11.87% return.
DFAI
- 1D
- 0.45%
- 1M
- 2.91%
- YTD
- 10.55%
- 6M
- 11.38%
- 1Y
- 25.58%
- 3Y*
- 17.58%
- 5Y*
- 9.68%
- 10Y*
- —
XBI
- 1D
- 1.95%
- 1M
- 4.37%
- YTD
- 11.87%
- 6M
- 11.41%
- 1Y
- 63.76%
- 3Y*
- 16.08%
- 5Y*
- 0.52%
- 10Y*
- 9.98%
DFAI vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
DFAI Dimensional International Core Equity Market ETF | 10.55% | 34.04% | 4.68% | 17.60% | -12.95% | 13.86% | 5.34% |
XBI SPDR S&P Biotech ETF | 11.87% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 11.21% |
Correlation
The correlation between DFAI and XBI is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.51 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.52 |
Correlation (All Time) Calculated using the full available price history since Nov 18, 2020 | 0.50 |
The correlation between DFAI and XBI has been stable across timeframes, ranging from 0.50 to 0.52 - a consistent structural relationship.
DFAI vs. XBI - Sectors Allocation Comparison
Sectors
DFAI
XBI
Financial Services
Industrials
-
Basic Materials
Consumer Cyclical
-
Healthcare
Technology
-
Energy
-
Consumer Defensive
-
Utilities
-
Communication Services
-
Real Estate
-
Financial Services
DFAI
XBI
Industrials
DFAI
XBI
-
Basic Materials
DFAI
XBI
Consumer Cyclical
DFAI
XBI
-
Healthcare
DFAI
XBI
Technology
DFAI
XBI
-
Energy
DFAI
XBI
-
Consumer Defensive
DFAI
XBI
-
Utilities
DFAI
XBI
-
Communication Services
DFAI
XBI
-
Real Estate
DFAI
XBI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DFAI vs. XBI — Risk / Return Rank
DFAI
XBI
DFAI vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dimensional International Core Equity Market ETF (DFAI) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DFAI | XBI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.69 | ||
| Sortino ratioReturn per unit of downside risk | -0.81 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.39 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 2.35 | 6.59 | -4.25 |
| Martin ratioReturn relative to average drawdown | 9.14 | 19.47 | -10.34 |
Loading charts...
Drawdowns
DFAI vs. XBI - Drawdown Comparison
The maximum DFAI drawdown since its inception was -27.44%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for DFAI and XBI.
Loading charts...
Drawdown Indicators
| DFAI | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -27.44% | -63.89% | +36.45% |
Max Drawdown (1Y)Largest decline over 1 year | -10.95% | -9.72% | -1.23% |
Max Drawdown (3Y)Largest decline over 3 years | -13.25% | -32.99% | +19.74% |
Max Drawdown (5Y)Largest decline over 5 years | -27.44% | -54.71% | +27.27% |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.89% | — |
Current DrawdownCurrent decline from peak | -0.35% | -21.16% | +20.81% |
Average DrawdownAverage peak-to-trough decline | -5.10% | -20.93% | +15.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.81% | 3.29% | -0.48% |
Volatility
DFAI vs. XBI - Volatility Comparison
The current volatility for Dimensional International Core Equity Market ETF (DFAI) is 5.12%, while SPDR S&P Biotech ETF (XBI) has a volatility of 10.55%. This indicates that DFAI experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DFAI | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.12% | 10.55% | -5.43% |
Volatility (6M)Calculated over the trailing 6-month period | 12.28% | 20.83% | -8.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.58% | 26.18% | -11.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.01% | 32.22% | -16.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.74% | 32.03% | -16.29% |
DFAI vs. XBI - Expense Ratio Comparison
DFAI has a 0.18% expense ratio, which is lower than XBI's 0.35% expense ratio.
Dividends
DFAI vs. XBI - Dividend Comparison
DFAI's dividend yield for the trailing twelve months is around 2.23%, more than XBI's 0.32% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DFAI Dimensional International Core Equity Market ETF | 2.23% | 2.45% | 2.72% | 2.64% | 2.72% | 2.06% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.32% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
DFAI and XBI have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (10.55%) compared to DFAI (5.12%). In terms of maximum drawdown, DFAI dropped -27.44% vs XBI's -63.89%.
On 5-year performance, DFAI leads with 9.68% vs 0.52% for XBI. On fees, DFAI is cheaper at 0.18% per year. On volatility, DFAI has been the lower-risk option at 5.12%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, DFAI has performed better with a 9.68% return vs 0.52%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
DFAI is cheaper with a 0.18% expense ratio, compared with 0.35% for XBI.
DFAI has the higher dividend yield at 2.23%, compared with 0.32% for XBI.
DFAI is categorized as Foreign Large Cap Equities, while XBI is Health & Biotech Equities. They also come from different issuers: Dimensional and State Street. Their fees differ too: 0.18% for DFAI and 0.35% for XBI.
XBI currently has the higher Sharpe Ratio (2.45 vs 1.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DFAI and XBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer